A leap forward in home entertainment, combining a super-bright 4K laser cinema with the convenience of Google TV and licensed Netflix access
TUMWATER, Wash., May 14, 2024 /PRNewswire/ — Dangbei, an innovator in smart entertainment, today announces the launch of its flagship model, Dangbei Mars Pro 2, the world’s first Google TV 4K laser projector with a built-in, licensed Netflix app. It marks the first projector to combine laser-illuminated Ultra HD picture, Dolby and DTS:X surround sound, the vast content universe of Google TV, and advanced smart controls. This makes it a truly all-in-one entertainment hub, transforming spaces into a movie theater, a gaming arena, or even a sports bar.

The Brightest Projector from Dangbei
Boasting a stellar 2450 ISO lumens powered by a laser light source, Dangbei Mars Pro 2 is Dangbei’s brightest projector to date. This translates to consistently vibrant visuals, day or night, for years to come. The premium 4K UHD picture with HDR10+ support offers a theater-quality experience, and the ALPD® technology ensures speckle-free and color fringing-free visuals.
Netflix and More at Fingertips
Mars Pro 2 makes streaming a breeze. The pre-installed, licensed Netflix app delivers smooth, stutter-free playback, taking Netflix viewing on projectors to new heights. Google TV’s intuitive interface allows for managing watchlists, multiple profiles, and getting personalized recommendations from all preferred streaming services, including Netflix, YouTube, Prime Video, Hulu, Disney+, and more.
Big Picture, Big Sound
Despite its compact size compared to traditional projectors, Mars Pro 2 can project expansive images up to 200 inches—over 2.5 times larger than a 75-inch TV. The immersive adventure goes beyond visuals. Mars Pro 2 boasts powerful sound with dual 12W built-in speakers, a spacious 600ml sound chamber, Dolby Audio, and DTS:X support, creating a next-level cinematic soundscape.
Smarter Image Optimization
Mars Pro 2 debuts Dangbei’s next-gen intelligent image optimization technology, InstanPro AI Image Setup. It leverages a combination of dToF, CMOS, and AI algorithms to offer a range of functionalities. Users can enjoy faster autofocus, auto keystone, screen fit, obstacle avoidance, eye protection, and AI brightness control—all designed for a perfect viewing experience.
Unleash Endless Entertainment
Dangbei Mars Pro 2 is a one-stop shop for entertainment. A dedicated game mode with low latency, 4K 60Hz refresh rate, HDMI 2.1, and WiFi 6 ensures seamless gameplay. MEMC technology smooths out fast-action for sporting events and more. Plus, Mars Pro 2 comes with 3D capabilities including Blu-ray, all delivered in whisper-quiet operation under 24 dB for uninterrupted enjoyment.
Pricing and Availability
Dangbei Mars Pro 2 will be officially released on May 28th, available both on the official website and Amazon US for $1899. To mark the occasion, Dangbei will offer a special discount of $400, bringing the price down to $1499. Customers can even claim a free gimbal stand (valued at $139) with their purchase of Mars Pro 2 on the Official Website, by subscribing to the newsletter prior to launch. 
The new product will also be available on Amazon UK/EU and other marketplaces like MediaMarkt, Fnac, Alza, Datart, and Allegro.
About Dangbei
Dangbei is a premium smart entertainment provider specializing in projectors and other innovative products. Trusted by over 200 million users worldwide, Dangbei offers stunning visuals and immersive sound, transforming spaces into vibrant entertainment, work, and life hubs.
In China, Dangbei leads in software for large screens, providing a vast app and content library across entertainment, health, education, and productivity. Dangbei ranks Top 2 in terms of shipments in China and Top 1 in the laser projector category. Learn more at us.dangbei.com.
Photo – https://mma.prnewswire.com/media/2397856/Mars_Pro_2.jpg

View original content:https://www.prnewswire.co.uk/news-releases/dangbei-to-unveil-mars-pro-2-worlds-first-google-tv-4k-laser-projector-with-licensed-netflix-302128312.html

CHICAGO, May 14, 2024 /PRNewswire/ — Biopharmaceutical Process Analytical Technology Market in terms of revenue was estimated to be worth $1.2 billion in 2024 and is poised to reach $2.6 billion by 2029, growing at a CAGR of 16.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

The global embrace of Process Analytical Technologies (PAT) is propelled by heightened research investment from biopharmaceutical firms, rigorous regulatory criteria for drug safety, improvements in drug quality, and technological advancements.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95920337
Browse in-depth TOC on “Biopharmaceutical Process Analytical Technology Market”
168 – Tables52 – Figures255 – Pages
Biopharmaceutical Process Analytical Technology Market Scope:
Report Coverage
Details
Market Revenue in 2024
$1.2 billion
Estimated Value by 2029
$2.6 billion
Growth Rate
Poised to grow at a CAGR of 16.0%
Market Size Available for
2022–2029
Forecast Period
2024–2029
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Type, Product Type, Mode, Application, and Region
Geographies Covered
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Healthcare costs are on the rise in developing nations
Key Market Drivers
Increasing demand for enhancing the quality of manufacturing processes
Liquid chrpmatography/HPLC segment to register significant growth rate over the forecast period of 2024-2029.
Based on the type, the global biopharmaceutical process analytical market has been classified into segments— liquid chromatography/HPLC, Gas chromatography, mass spectrometry, real-time PCR/QPCR, NGS, NMR spectroscopy, raman spectroscopy, infrared spectroscopy, particle counters and imaging, differential light scattering, and other techniques. Liquid chromatography/HPLC segment is anticipated to register significant growth. The wide-ranging use of chromatography within the biopharmaceutical sector, spanning tasks such as quantifying pharmaceutical compounds, identifying pathogens, measuring proteins, and supporting biochemistry and biophysics investigations, emphasizes its significance. Moreover, stringent regulatory standards governing drug development and safety play a significant role in driving its global growth.
Analyzers segment accounted for the largest share of the biopharmaceutical process analytical technology, by product type market in 2023.
Based on product type, Analyzers segment dominates the biopharmaceutical process analytical technology market, and the trend is expected to continue over the forecast period. In 2023, This sector claimed the largest share due to advancements in process analytical techniques, which provide operational efficiency and decrease process cycle times.
Online analysis segment dominated the market in terms of measurement, in 2023.
Based on mode, In 2023, the dominant segment in the biopharmaceutical process analytical technology tools market was online analysis. The swift processing and dependable outcomes were credited to the efficient monitoring of crucial process parameters (CPP) throughout drug development and manufacturing. A range of analytical methods, such as on-line, in-line, at-line, and off-line approaches, were utilized to effectively analyze CPP.
North America market to hold major share in the market during the forecast period.
Based on region, North America, comprising the US and Canada, accounted for the largest share of the global biopharmaceutical process analytical technology market in 2023. The primary factors fueling this market encompass the availability of research funding, stringent regulations overseeing drug development, and the increasing prevalence of conferences, discussions, symposiums, and seminars centered around analytical technologies.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=95920337
Biopharmaceutical Process Analytical Technology Market Dynamics:
Drivers:
Increasing demand for enhancing the quality of manufacturing processesRestraints:
High cost of PAT deploymentOpportunities:
Healthcare costs are on the rise in developing nationsChallenge:
Lack of skilled professionalsKey Market Players of Biopharmaceutical Process Analytical Technology Industry:
As of 2023, prominent players in the biopharmaceutical process analytical technology market are Waters Corporation (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Bruker Corporation (US), Emerson Electric Co. (US), ABB Ltd. (Switzerland), PerkinElmer, Inc. (US), Mettler-Toledo International Inc. (US), and Carl Zeiss AG (Germany), among others.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1 30%, Tier 2–42%, and Tier 3– 28%By Designation: C-level–14%, D Level–10%, and Others–76%By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=95920337
Recent Developments of Biopharmaceutical Process Analytical Technology Industry:
In Feb 2024, Thermo Fisher Scientific Inc. introduced the Thermo Scientific Dionex Inuvion Ion Chromatography (IC) system, aimed at simplifying, and enhancing ion analysis across laboratories of varying scales. This innovative analytical instrument offers easy reconfiguration, serving as a comprehensive solution for the precise determination of ionic and small polar compounds, ensuring consistent and reliable results.In April 2022, Thermo Fisher Scientific Inc. has introduced the Ramina Process Analyzer, a Raman spectroscopic analyzer aimed at simplifying Raman spectroscopy measurements to enhance user accessibility by reducing complexity.In June 2021, Agilent Technologies Inc. launched three InfinityLab Bio LC systems have been introduced by the company, tailored to address the increasing demands of the biopharmaceutical sector.Biopharmaceutical Process Analytical Technology Market – Key Benefits of Buying the Report:
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the biopharmaceutical process analytical technology marketProduct Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the biopharmaceutical process analytical technology marketMarket Development: Comprehensive information on lucrative emerging regionsMarket Diversification: Exhaustive information about new products, growing geographies, and recent developments in the biopharmaceutical process analytical technology marketCompetitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.Related Reports:
Biomarkers Market – Global Forecasts to 2028
Epigenetics Market – Global Forecasts to 2028
Preimplantation Genetic Testing Market – Global Forecasts to 2028
Molecular Diagnostics Market – Global Forecasts to 2028
Life Science Instrumentation Market – Global Forecasts to 2028
Get access to the latest updates on Biopharmaceutical Process Analytical Technology Companies and Biopharmaceutical Process Analytical Technology Industry
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Aashish MehraMarketsandMarkets™ INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [email protected] Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

View original content:https://www.prnewswire.co.uk/news-releases/biopharmaceutical-process-analytical-technology-market-worth-2-6-billion–marketsandmarkets-302144538.html

SAN FRANCISCO, May 14, 2024 /PRNewswire/ — Hevo Data, a leading ELT platform, today announced their inclusion on Snowflake Partner Connect on the Snowflake Data Cloud. This launch allows Snowflake users to directly access Hevo Data within the Snowflake platform, streamlining the data engineering process for joint customers and boosting the performance of analytics teams.

“With Snowflake Partner Connect, we’re staying true to our goal of enabling data-driven decisions for businesses,” said Manish Jethani, co-founder and CEO of Hevo Data. “We hope to increase accessibility and streamline the Modern Data Stack for our joint customers, bringing a new paradigm of smoother data processes within organizations.” 
Data teams often struggle to reliably integrate siloed data, sometimes requiring months of effort to setup and maintain ETL pipelines. Hevo Data’s flexible, easy-to-use platform enables data teams to automate data integration at scale. By leveraging the Snowflake Data Cloud, Hevo Data is joining Snowflake in mobilizing the world’s data and helping organizations to unlock higher levels of analytics, data science and data-driven decision-making. 
“Today’s announcement further illustrates Hevo Data’s commitment to helping Snowflake mobilize the world’s data,” said Tarik Dwiek, Head of Technology Alliances at Snowflake. “By bringing Hevo Data’s ELT platform into the Snowflake Data Cloud we’re continuing to enable reliable, flexible data movement through Snowflake’s single, integrated platform for our ecosystem.”
By being featured on Snowflake Partner Connect, Hevo Data will enable joint customers to access seamless connectivity between the two platforms, building upon the already synchronous relationship between the two. For example, Deliverr by Flexport was able to save 2 man-weeks per month and improve query latency by 25-40% by switching to a combination of Hevo and Snowflake.
“Hevo helps us centralize our data on Snowflake and effectively use it for reporting. Deliverr’s product and engineering teams manage their own set of microservices, and each team creates Hevo pipelines on its own without needing help from data engineers or DevOps,” said Emmet Murphy, Staff Software Engineer at Deliverr.
About Hevo Data: Hevo Data is an intuitive data pipeline platform that data teams across 40+ countries rely on to fuel data-driven decisions. Hevo Data helps them reliably and effortlessly sync data from 150+ SaaS apps and other data sources to any cloud warehouse or data lake and turn it analytics-ready through models and workflows. Learn more about Hevo Data here: www.hevodata.com. 
Logo – https://mma.prnewswire.com/media/2410440/Hevo_Data_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/hevo-data-joins-snowflake-partner-connect-on-the-data-cloud-302143254.html